Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.8000
+0.0250 (3.23%)
At close: Dec 3, 2025
Genetic Analysis AS Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Operating Revenue | 16.53 | 15.89 | 14.15 | 11.16 | 6.8 | 5.78 | Upgrade |
Other Revenue | 5.15 | 4.8 | 9.02 | 9.58 | 6.58 | 1.76 | Upgrade |
| 21.68 | 20.68 | 23.16 | 20.75 | 13.38 | 7.54 | Upgrade | |
Revenue Growth (YoY) | 9.98% | -10.71% | 11.65% | 55.08% | 77.51% | -31.81% | Upgrade |
Cost of Revenue | 3.94 | 3.32 | 4.6 | 3.91 | 1.28 | 1.03 | Upgrade |
Gross Profit | 17.74 | 17.36 | 18.57 | 16.84 | 12.1 | 6.51 | Upgrade |
Selling, General & Admin | 13.09 | 16.83 | 20.72 | 22.31 | 20.39 | 14.68 | Upgrade |
Other Operating Expenses | 8.95 | 9.78 | 16.23 | 17.88 | 16.05 | 7.8 | Upgrade |
Operating Expenses | 27.46 | 31.85 | 42.52 | 45.02 | 40.97 | 27.28 | Upgrade |
Operating Income | -9.72 | -14.49 | -23.96 | -28.18 | -28.87 | -20.77 | Upgrade |
Interest Expense | -0.08 | -0.36 | -0.25 | -0.12 | -0.13 | -0.21 | Upgrade |
Interest & Investment Income | 0.4 | 0.42 | 0.36 | 0.03 | - | 0.03 | Upgrade |
Earnings From Equity Investments | -0.62 | -0.62 | -0.09 | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | 0.27 | 0.27 | 0.03 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | -0 | -0 | 0.09 | -0 | - | - | Upgrade |
EBT Excluding Unusual Items | -9.75 | -14.77 | -23.82 | -28.27 | -29.01 | -20.95 | Upgrade |
Asset Writedown | - | - | - | - | - | -1.4 | Upgrade |
Other Unusual Items | - | - | - | - | - | 0.22 | Upgrade |
Pretax Income | -9.75 | -14.77 | -23.82 | -28.27 | -29.01 | -22.14 | Upgrade |
Net Income | -9.75 | -14.77 | -23.82 | -28.27 | -29.01 | -22.14 | Upgrade |
Net Income to Common | -9.75 | -14.77 | -23.82 | -28.27 | -29.01 | -22.14 | Upgrade |
Shares Outstanding (Basic) | 60 | 45 | 26 | 25 | 25 | 17 | Upgrade |
Shares Outstanding (Diluted) | 60 | 45 | 26 | 25 | 25 | 17 | Upgrade |
Shares Change (YoY) | 33.71% | 70.99% | 4.61% | 0.07% | 45.72% | 49.90% | Upgrade |
EPS (Basic) | -0.16 | -0.33 | -0.91 | -1.13 | -1.16 | -1.29 | Upgrade |
EPS (Diluted) | -0.16 | -0.33 | -0.91 | -1.13 | -1.16 | -1.29 | Upgrade |
Free Cash Flow | 0.89 | -8.96 | -17.38 | -19.69 | -27.7 | -6.58 | Upgrade |
Free Cash Flow Per Share | 0.01 | -0.20 | -0.66 | -0.79 | -1.11 | -0.38 | Upgrade |
Gross Margin | 81.81% | 83.93% | 80.15% | 81.17% | 90.42% | 86.37% | Upgrade |
Operating Margin | -44.84% | -70.03% | -103.41% | -135.84% | -215.80% | -275.56% | Upgrade |
Profit Margin | -44.96% | -71.40% | -102.82% | -136.28% | -216.80% | -293.70% | Upgrade |
Free Cash Flow Margin | 4.09% | -43.29% | -75.02% | -94.88% | -207.07% | -87.30% | Upgrade |
EBITDA | -9.3 | -14.24 | -23.77 | -28 | -28.7 | -20.57 | Upgrade |
EBITDA Margin | -42.91% | -68.82% | -102.61% | -134.95% | -214.56% | -273.00% | Upgrade |
D&A For EBITDA | 0.42 | 0.25 | 0.19 | 0.19 | 0.17 | 0.19 | Upgrade |
EBIT | -9.72 | -14.49 | -23.96 | -28.18 | -28.87 | -20.77 | Upgrade |
EBIT Margin | -44.84% | -70.03% | -103.41% | -135.84% | -215.80% | -275.56% | Upgrade |
Revenue as Reported | 21.68 | 20.68 | 23.16 | 20.75 | 13.38 | 7.75 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.